exp561 has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Hemrick-Luecke, SK; Robertson, DW | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Perry, KW | 1 |
2 other study(ies) available for exp561 and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Bridged Bicyclo Compounds; Cerebral Cortex; Corpus Striatum; Desipramine; Heart; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine; Pyridines; Pyridinium Compounds; Spleen; Time Factors | 1988 |
Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain; Bridged Bicyclo Compounds; Cyclopropanes; Dose-Response Relationship, Drug; Isoenzymes; Lethal Dose 50; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Pyridines; Pyridinium Compounds; Salivation; Selegiline | 1988 |